Sensei Biotherapeutics’ (SNSE) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Sensei Biotherapeutics (NASDAQ:SNSE) in a research note published on Friday morning,Benzinga reports. HC Wainwright currently has a $4.00 target price on the stock.

Sensei Biotherapeutics Price Performance

NASDAQ SNSE opened at $0.51 on Friday. The stock has a market capitalization of $12.78 million, a P/E ratio of -0.43 and a beta of 0.16. The firm’s 50-day moving average is $0.47 and its two-hundred day moving average is $0.49. Sensei Biotherapeutics has a 12 month low of $0.38 and a 12 month high of $1.94.

Sensei Biotherapeutics (NASDAQ:SNSE) last issued its quarterly earnings data on Friday, March 28th. The company reported ($0.27) EPS for the quarter, hitting the consensus estimate of ($0.27). As a group, analysts anticipate that Sensei Biotherapeutics will post -1.17 EPS for the current year.

Institutional Investors Weigh In On Sensei Biotherapeutics

A hedge fund recently raised its stake in Sensei Biotherapeutics stock. National Bank of Canada FI raised its position in Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) by 355.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,575 shares of the company’s stock after acquiring an additional 35,575 shares during the quarter. National Bank of Canada FI owned approximately 0.18% of Sensei Biotherapeutics worth $27,000 as of its most recent SEC filing. Institutional investors and hedge funds own 10.50% of the company’s stock.

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.